Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | March 16, 2023 09:06am

Gainers

  • Lipella Pharmaceuticals (NASDAQ:LIPO) stock increased by 48.4% to $2.71 during Thursday's pre-market session. The market value of their outstanding shares is at $15.5 million.
  • SQZ Biotechnologies (NYSE:SQZ) stock rose 24.52% to $0.66. The market value of their outstanding shares is at $19.4 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 17.87% to $3.1. The company's market cap stands at $40.0 million.
  • IN8bio (NASDAQ:INAB) shares rose 16.54% to $1.55. The company's market cap stands at $37.9 million.
  • OKYO Pharma (NASDAQ:OKYO) shares moved upwards by 15.99% to $2.03. The company's market cap stands at $44.1 million.
  • Xtant Medical Hldgs (AMEX:XTNT) shares moved upwards by 14.07% to $0.75. The market value of their outstanding shares is at $82.0 million.

Losers

  • Esperion Therapeutics (NASDAQ:ESPR) stock declined by 60.8% to $1.56 during Thursday's pre-market session. The market value of their outstanding shares is at $119.4 million.
  • Gracell Biotechnologies (NASDAQ:GRCL) shares declined by 15.39% to $1.54. The market value of their outstanding shares is at $104.2 million. The company's, Q4 earnings came out 3 days ago.
  • electroCore (NASDAQ:ECOR) shares decreased by 12.36% to $3.05. The market value of their outstanding shares is at $14.4 million.
  • Aveanna Healthcare Hldgs (NASDAQ:AVAH) stock declined by 12.09% to $1.31. The market value of their outstanding shares is at $243.5 million. The company's, Q4 earnings came out today.
  • Paratek Pharmaceuticals (NASDAQ:PRTK) shares fell 12.05% to $1.68. The company's market cap stands at $93.3 million. As per the press release, Q4 earnings came out today.
  • Pear Therapeutics (NASDAQ:PEAR) shares decreased by 10.96% to $0.53. The market value of their outstanding shares is at $74.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVAH ECOR ESPR GRCL INAB LIPO MNPR OKYO PEAR PRTK SQZ XTNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist